Anlotinib as treatment for advanced non-small cell lung cancer: A systematic review and meta-analysis on overall survival and progression free survival

被引：0
|
作者：
Susanto, B. [1 ]
Marcella, E. [1 ]
Chen, S. [1 ]
Heriyanto, R. S. [1 ]
Tandiono, J. [1 ]
Wijovi, F. [1 ]
Tancherla, A. [1 ]
Kurniawan, A. [2 ]
机构：
[1] Pelita Harapan Univ, Fac Med, Tangerang, Indonesia
[2] Pelita Harapan Univ, Dept Internal Med, Tangerang, Indonesia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
172P
引用
收藏
页码：S792 / S792
页数：1
相关论文
共 50 条
  • [1] Meta-analysis of progression-free survival as a predictor of overall survival in locally advanced or metastatic non-small cell lung cancer trials.
    Turner, Evadne Jane
    McCloud, Philip
    Germanos, Peter
    Dehle, Francis
    Norris, Sarah
    Tan, Jonathan
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] Association between event-free survival and overall survival after neoadjuvant treatment for non-small cell lung cancer: a systematic review and meta-analysis
    Ostoros, Gyula
    Hettle, Robert
    Georgoulia, Nefeli
    Berktas, Mehmet
    Chander, Pratibha
    Perez, Ignacio Diaz
    Couto, Anne-Marie
    Eichinger, Christian
    Field, Polly
    Morten, Peter
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (12) : 1305 - 1313
  • [3] Impact of EGFR Inhibitor in Non-Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis
    Lee, Chee Khoon
    Brown, Chris
    Gralla, Richard J.
    Hirsh, Vera
    Thongprasert, Sumitra
    Tsai, Chun-Ming
    Tan, Eng Huat
    Ho, James Chung-Man
    Chu, Da Tong
    Zaatar, Adel
    Osorio Sanchez, Jemela Anne
    Vu Van Vu
    Au, Joseph Siu Kie
    Inoue, Akira
    Lee, Siow Ming
    Gebski, Val
    Yang, James Chih-Hsin
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (09): : 595 - 605
  • [4] Atezolizumab as first-line therapy for patients with advanced non-small cell lung cancer: A systematic review and meta-analysis on overall survival
    Marcella, E.
    Susanto, B.
    Chen, S.
    Tandiono, J.
    Tancherla, A.
    Heriyanto, R. S.
    Wijovi, F.
    Kurniawan, A.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S759 - S759
  • [5] Correlation between progression-free and overall survival in a meta-analysis of aggregated survival data from patients with non-small cell lung cancer
    Aksenov, Sergey
    Lee, Daniel
    Edlund, Helena
    Minchella, Kaitlyn
    Xu, Hongmei
    Dunyak, James
    Al-Huniti, Nidal
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S63 - S64
  • [6] Overall Survival of Non-Small Cell Lung Cancer With Spinal Metastasis A Systematic Review and Meta- Analysis
    Tsuang, Fon-Yih
    Jeon, Jin Pyeong
    Huang, An-Ping
    Chai, Chung Liang
    NEUROSPINE, 2023, 20 (02) : 567 - 576
  • [7] Treatment beyond progression in non-small cell lung cancer: A systematic review and meta-analysis
    Kuo, Wei-Ke
    Weng, Ching-Fu
    Lien, Yin-Ju
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [8] Immune checkpoint proteins as a prognostic biomarker of overall survival in non-small cell lung cancer: A meta-analysis and systematic review
    Tan, H. N.
    Rodriguez, C. C.
    Monte, K. A.
    Tan, P. G.
    Cornelio, G. D. H.
    ANNALS OF ONCOLOGY, 2020, 31 : S283 - S283
  • [9] Anlotinib for refractory advanced non-small-cell lung cancer: A systematic review and meta-analysis
    Yu, Guocan
    Shen, Yanqin
    Xu, Xudong
    Zhong, Fangming
    PLOS ONE, 2020, 15 (11):
  • [10] Antibiotic treatment and survival in non-small cell lung cancer patients receiving immunotherapy: a systematic review and meta-analysis
    Abdelhamid, Arwa
    Tuminello, Stephanie
    Ivic-Pavlicic, Tara
    Flores, Raja
    Taioli, Emanuela
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (12) : 2427 - 2439
12345